On September 11, 2020 CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, reported that it will be presenting at the H.C. Wainwright 22nd Annual Global Investment Conference (Press release, Cel-Sci, SEP 11, 2020, View Source [SID1234565030]). The virtual conference will be held on September 14-16, 2020. Geert Kersten, Chief Executive Officer of CEL-SCI, will present on Monday, September 14 at 1:30 p.m. ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

For those who wish to listen to the live webcast, please use the following link View Source The webcast will be archived on CEL-SCI’s investor relations website, View Source for 90 days following the live presentation.

On September 11, 2020 Eli Lilly and Company (NYSE: LLY) reported that it will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, September 16, 2020. Joshua Smiley, senior vice president and Lilly’s chief financial officer, will participate in a virtual fireside chat at 3:30 p.m., Eastern Time (Press release, Eli Lilly, SEP 11, 2020, View Source [SID1234565031]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly’s Investor website at View Source A replay of the presentation will be available on this same website for approximately 90 days.

On September 11, 2020 Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, reported that the company will participate in the 18th Annual Morgan Stanley Virtual Global Healthcare Conference in September (Press release, Ascendis Pharma, SEP 11, 2020, View Source [SID1234565016]). Company executives will provide a business overview and update on the company’s pipeline programs.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details

Event 18th Annual Morgan Stanley Virtual Global Healthcare Conference
Location Virtual
Date Thursday, September 17, 2020
Time 3:30 p.m. Eastern Time
A live webcast of the presentation will be available in the Investors and News section of the Ascendis Pharma website at www.ascendispharma.com. A webcast replay will also be available on this website shortly after conclusion of the events for 30 days.

On September 11, 2020 AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") reported it will be featured as a presenting company at the H.C. Wainwright 22nd Annual Global Investment Conference (Press release, AIkido Pharma, SEP 11, 2020, https://www.prnewswire.com/news-releases/aikido-pharma-inc-announces-participation-at-the-hc-wainwright-22nd-annual-global-investment-conference-on-september-14-16-2020-virtual-conference-301128171.html [SID1234565032]). The conference is being held on September 14-16, 2020 virtually.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Darrell Dotson, Vice President and General Counsel, of AIkido Pharma Inc. will provide an overview of the Company’s business during the live presentation.

If you are an institutional investor, and would like to attend the Company’s presentation, please click on the following link (www.hcwevents.com ) to register for the conference.

Event: H.C. Wainwright 22nd Annual Global Investment Conference (Virtual Conference)
Date: Tuesday, September 15, 2020
Time: 3:00 p.m. (Eastern Time)
Location: Virtual Conference
Webcast: View Source

The presentation will be webcast live. To access the webcast, please visit www.hcwevents.com . The webcast replay will remain available for 90 days following the live presentation.

About H.C. Wainwright

H.C. Wainwright is a full–service investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. H.C. Wainwright & Co. also provides research and sales and trading services to institutional investors. According to Sagient Research Systems, H.C. Wainwright’s team is ranked as the #1 Placement Agent in terms of aggregate CMPO (confidentially marketed public offering), RD (registered direct offering) and PIPE (private investment in public equity) executed cumulatively since 1998.

On September 11, 2020 Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, reported that the company will participate in the following September investor conferences (Press release, Magenta Therapeutics, SEP 11, 2020, View Source [SID1234565017]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor Virtual Global Healthcare Conference, presentation at 8:00 a.m. ET on Wednesday, September 16
Oppenheimer Virtual Fall Healthcare Life Sciences & MedTech Summit, presentation at 10:50 a.m. ET on Wednesday, September 23
Live webcasts can be accessed on the Magenta Therapeutics website at View Source The webcast replays will be available for 90 days following each event.